Choose year: See all 29/11/2019 Grupo Biotoscana announces closing of Sale of Control 21/10/2019 Grupo Biotoscana announces change in management 26/02/2019 JAVLOR® approved in Chile Montevideo, Uruguay March 28, 2018. JAVLOR® is indicated in monotherapy for the treatment of adult patients with advanced or metastatic […] Veja mais` 15/12/2018 World Pancreatic Cancer Day World Pancreatic Cancer Day Demand better. For patients. For survival. Montevideo, Uruguay, November 15, 2018. To honor the World Pancreatic […] Veja mais` 29/11/2019 Grupo Biotoscana announces closing of Sale of Control Sale of Control – Closing Montevidéu, November 29th, 2019 – BIOTOSCANA INVESTMENTS S.A. (“Company” or “GBT”) (B3: GBIO33), a leading […] Veja mais 21/10/2019 Grupo Biotoscana announces change in management Grupo Biotoscana announces change in management Montevideo, October 21st, 2019 – BIOTOSCANA INVESTMENTS S.A. today announced the appointment of Mr. […] Veja mais 26/02/2019 JAVLOR® approved in Chile Montevideo, Uruguay March 28, 2018. JAVLOR® is indicated in monotherapy for the treatment of adult patients with advanced or metastatic […] Veja mais 15/12/2018 World Pancreatic Cancer Day World Pancreatic Cancer Day Demand better. For patients. For survival. Montevideo, Uruguay, November 15, 2018. To honor the World Pancreatic […] Veja mais 31/10/2018 Myelodysplastic Syndrome Awareness Campaign Grupo Biotoscana promove campanha Veja mais 25/10/2018 Myelodysplastic Syndrome World Awareness Day Myelodysplastic Syndrome World Awareness Day Grupo Biotoscana interviews Dr. Breno Moreno de Gusmão. Montevideo, Uruguay, October 25, 2018. To celebrate […] Veja mais 04/10/2018 New regulatory approvals Grupo Biotoscana anuncia novas Veja mais 01/10/2018 #GBTRosa2018 – Breast cancer awareness campaign Grupo Biotoscana participates in the worldwide breast cancer awareness campaign during the month of October. Veja mais 28/09/2018 Approval of CRESEMBA® in Argentina Grupo Biotoscana announces approval of antifungal CRESEMBA® in Argentina. Veja mais 05/09/2018 13th Cancer de Mama (Breast Cancer) – Gramado 13th Cancer de Mama (Breast Cancer) – Gramado Grupo Biotoscana participates in the 2018 edition. Montevideo, Uruguay, September 5, 2018. […] Veja mais 22/08/2018 16th Infocus 2018 16th Infocus 2018 The most important Latin American event in Clinical Mycology Montevideo, Uruguay, August 22, 2018. GBT Grupo Biotoscana […] Veja mais 27/07/2018 World Hepatitis Day 2018 World Hepatitis Day 2018 The diagnosis and timely treatment of viral hepatitis can save lives. Montevideo, Uruguay, July 27, 2018. […] Veja mais 29/06/2018 Approval of CRESEMBA® and ZEVTERA® in Peru Approval of CRESEMBA® and ZEVTERA® in Peru Grupo Biotoscana announces first approval of antifungal CRESEMBA® in Latam and approval of […] Veja mais 06/06/2018 2018 Asco Annual Meeting 2018 Asco Annual Meeting GBT attended the 2018 ASCO Annual Meeting in Chicago. Montevideo, Uruguay June 6, 2018. Between June […] Veja mais 10/05/2018 Extension of agreement with Gilead Extension of agreement with Gilead Grupo Biotoscana announces new agreement with Gilead for the Andean region. Montevideo, Uruguay May 10, […] Veja mais 23/04/2018 Launch of LENVIMA® in Brazil Launch of LENVIMA® in Brazil LENVIMA®’s first steps in the Brazilian market. Montevideo, Uruguay April 23, 2018. From April 19th […] Veja mais 17/04/2018 World hemophilia day 2018 World hemophilia day 2018 Grupo Biotoscana joins the world hemophilia day campaign. Montevideo, Uruguay April 17, 2018. On World Hemophilia […] Veja mais 12/03/2018 New initiatives for LENVIMA® New initiatives for LENVIMA® Grupo Biotoscana announces new initiatives for LENVIMA®. Montevideo, Uruguay March 12, 2018. BIOTOSCANA INVESTMENTS S.A. (“Company” […] Veja mais 10/03/2018 Colombian Congress of Vascular Surgery and Angiology 2018 Colombian Congress of Vascular Surgery and Angiology 2018 GBT sponsored the XXII Colombian Congress of Vascular Surgery and Angiology 2018. […] Veja mais 06/03/2018 Launch of ZEVTERA® in Argentina Launch of ZEVTERA® in Argentina Grupo Biotoscana announces launch of antibiotic ZEVTERA® (ceftobiprole) in Argentina. Montevideo, Uruguay, March 6, 2018. GBT-Grupo […] Veja mais 02/03/2018 Extension of agreement with Biocad Extension of agreement with Biocad Grupo Biotoscana announces extension of agreement with Biocad to include exclusive license for Infliximab in […] Veja mais 12/01/2018 J.P. Morgan Healthcare Conference J.P. Morgan Healthcare Conference Between January 8 and 11, GBT attended the J.P. Morgan Healthcare Conference in San Francisco, California. […] Veja mais 05/12/2017 HARVONI® approved in Brazil HARVONI® approved in Brazil Grupo Biotoscana expects to introduce the product into the market in 2Q18. Montevideo, Uruguay, December 5, […] Veja mais 01/11/2017 Launch of ABRAXANE® / ABRAXUS® Launch of ABRAXANE® / ABRAXUS® Grupo Biotoscana announces the launched of ABRAXANE® / ABRAXUS® in Brazil and Mexico. Montevideo, Uruguay, […] Veja mais 03/10/2017 Exclusive licensing agreement with Eisai Exclusive licensing agreement with Eisai Grupo Biotoscana and EISAI sign exclusive licensing agreement for four novel oncology and neurology products […] Veja mais Veja maisLess News